Publication Topic

Kaonga N, Patterson E, Sanchez-Medina MC, Pete T, Rilo N, Reardon E, Eugley S, Frankenfeld C, Fitzgerald T. 2026. The route of misoprostol in reducing blood loss for transperitoneal myomectomies: A systematic review and meta-analysis. OG Open 3(1):e151; doi: 10.1097/og9.0000000000000151. PMID: 41727925.

Bylsma LC, Gage SM, Reichert H, Dahl SLM, Lawson JH. 2017. Arteriovenous fistulas for hemodialysis: A systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg 54(4):513-522; doi: 10.1016/j.ejvs.2017.06.024. PMID: 28843984.

Rehn M, Chia V, Younan D, Hooda N, Fryzek J, Suh M, Mezzi K, Soeda J. 2024. An updated systematic literature review of safety and efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus Bevacizumab in adult patients with RAS wild-type left-sided metastatic colorectal cancer. PROSPERO 2024:CRD42022338784. Available from:  https://www.crd.york.ac.uk/PROSPERO/view/CRD42022338784.

Nielson CM, Bylsma LC, Fryzek JP, Saad HA, Crawford J. 2021. Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: A systematic review and meta-analysis. Oncologist 26(9):e1609–e1618; doi: 10.1002/onco.13822. PMID: 33973301.

Fryzek J, Suh M, Movva N, Bylsma L. 2020. Protocol: Systematic literature review and meta-analysis of respiratory syncytial virus (RSV) testing patterns, RSV burden, and RSV clinical sequalae among infants and children up to 5 years of age living in the United States. PROSPERO CRD42020162991.

Levin-Sparenberg E, Bylsma LC, Lowe K, Sangare L, Fryzek JP, Alexander DD. 2020. A systematic literature review and meta-analysis describing the prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer. Gastroenterol Res 13(5):184–198; doi: 10.14740/gr1167. PMID: 33224365.

Stalbovskaya V, Wasserman E, Fryzek J, Bylsma L, Sirulnik A. NRG1 fusion-driven cancers: A systematic literature review and meta-analysis. Abstract, Annual Meeting of the American Society of Clinical Oncology, May 2020.

Bylsma LC, Gillezeau C, Garawin TA, Kelsh MA, Fryzek JP, Sangaré L, et al. 2020. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer Med 9(3):1044–1057; doi: 10.1002/cam4.2747. PMID: 31856410.

Bylsma LC, Dean R, Lowe K, Sangaré L, Alexander DD, Fryzek JP. 2019. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics. Cancer Med 8(12):5800–5809; doi: 10.1002/cam4.2413. PMID: 31376243.

Bylsma LC, Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.